High incidence of atrial fibrillation in patients treated with ibrutinib.

Florian BaptisteJennifer CautelaYan AncedyNoémie ResseguierThérèse AurranLaure FarnaultMarion EscudierChloé AmmarMélanie GaubertCharles DolladilleJeremie BarraudMichael PeyrolAriel CohenFranck PaganelliJoachim AlexandreStephane EderhyYuichi Tamura

Published in: Open heart (2019)

This cardio-oncology study showed that the risk of IRAF was much higher than previously reported. The majority of cases occurred in asymptomatic patients justifying close monitoring.

Keyphrases

end stage renal disease
atrial fibrillation
ejection fraction
chronic kidney disease
newly diagnosed
palliative care
peritoneal dialysis
prognostic factors
risk factors
heart failure
left atrial
direct oral anticoagulants
oral anticoagulants
left atrial appendage
patient reported